At Kite, a Gilead company, our singular focus is cell therapy to treat and cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
We believe cell therapy has the ability to change the way cancer is treated. Our cell therapy technology uses the power of a patient's own immune system (their white blood cells) to target and attack their cancer cells.
About cell therapy
Kite, a Gilead company
Staying Up To Date
News & insights
Everything you need to know
Yescarta ®
Everything you need to know
Tecartus ®
Videos, webinars, podcasts and much more
CAR-T Academy
About the team
Local cell therapy team
CAR-T centres, Treatment & reimbursement criteria
Referring patients: Yescarta ®
CAR-T centres, Treatment & reimbursement criteria
Referring patients: Tecartus®
We respect your privacy. If you want to know what we do with the information we collect about you and why we request it, you can read our privacy statement.
For the most recent version of the SmPC, please refer to the EMA website: Yescarta / Tecartus
A grading method and treatment algorithm for patients receiving cellular therapy.